EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incidence of human papillomavirus–related cancers among males and females aged 15-34 years in the United States

Fangjian Guo iD, Victor Adekanmbi, Christine D Hsu, Abbey B Berenson

JNCI Cancer Spectrum · 2023

DOI: 10.1093/jncics/pkad016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2023. Verfasst von Fangjian Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA. Hauptthemen laut MEDLINE: Papillomavirus Infections, Neoplasms, Papillomavirus Vaccines. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAMS NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Postmarket surveillance of the incidence of human papillomavirus (HPV)–related cancers is essential to monitor the effectiveness of HPV vaccines. We directly compared HPV-related cancer incidences during the pre- and postvaccine era to assess the effects of HPV vaccination among vaccine-eligible age groups in the United States using data from the US Cancer Statistics database. The 5-year average annual incidence rates for HPV-related cancers decreased in 2015-2019 compared with 2002-2006 among females aged 15-24 years and 25-34 years. Overall, a decrease in young males was not observed, whereas males aged 25-34 years experienced a slight decline in oropharyngeal squamous cell carcinoma between 2005-2009 and 2015-2019. Incidence rates for HPV-related cancers statistically significantly decreased in the vaccine era compared with the prevaccine era among females aged 15-34 years, suggesting the potential early effects of the introduction of HPV vaccination in the United States.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsNeoplasmsPapillomavirus VaccinesMaleHumansFemaleUnited StatesHuman Papillomavirus VirusesIncidence

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.
  • Center for Interdisciplinary Research in Women's Health, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.

ORCID-Profile: Fangjian Guo

Förderung

  • NCI NIH HHS
  • NIAMS NIH HHS
  • NICHD NIH HHS
  • National Institutes of Health

Zitieren

APA

Guo, F., Adekanmbi, V., Hsu, C. D., & Berenson, A. B. (2023). Incidence of human papillomavirus–related cancers among males and females aged 15-34 years in the United States. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkad016

Vancouver

Guo F, Adekanmbi V, Hsu CD, Berenson AB. Incidence of human papillomavirus–related cancers among males and females aged 15-34 years in the United States. JNCI Cancer Spectrum. 2023. doi:10.1093/jncics/pkad016

BibTeX
@article{Guo2023,
  author = {Guo, Fangjian and Adekanmbi, Victor and Hsu, Christine D and Berenson, Abbey B},
  title = {Incidence of human papillomavirus–related cancers among males and females aged 15-34 years in the United States},
  journal = {JNCI Cancer Spectrum},
  year = {2023},
  doi = {10.1093/jncics/pkad016}
}
Kostenlos starten →